Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
about
Prevention of Hepatitis B reactivation in the setting of immunosuppressionImmunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel diseaseInterventions and targets aimed at improving quality in inflammatory bowel disease ambulatory careTumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewWhat is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?Preventive health measures in inflammatory bowel diseaseBiological treatment of Crohn's disease.Preparing for biologic or immunosuppressant therapy.Updates in vaccination: recommendations for adult inflammatory bowel disease patients.Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region.Evaluation of factors associated with response to hepatitis B vaccination in patients with inflammatory bowel diseaseVaccines and recommendations for their use in inflammatory bowel disease.Prevention of infection caused by immunosuppressive drugs in gastroenterology.Clinical efficacy maintains patients' positive attitudes toward fecal microbiota transplantation.Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India.A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.Crohn's disease: the subsequent visit.Hepatitis B virus reactivation associated with anti-neoplastic therapy.Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxisEfficacy of the vaccination in inflammatory bowel disease.Systematic review with meta-analysis: inflammatory bowel disease in the elderly.Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.Health maintenance and inflammatory bowel disease.Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.Infection risk associated with anti-TNF-α agents: a review.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.The safety of treatment options for pediatric Crohn's disease.Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study.Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.Improving care for inflammatory bowel disease patients infected with hepatitis B virus.Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases.Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases.
P2860
Q26747023-12D5F1C1-10C0-40F4-979D-3104CFC8E7CEQ26777330-A96F0FA1-43C9-4E84-976E-0F3EFFBF956DQ26823569-6FDB9F6A-5EEE-43DA-8517-208DBEC45041Q26829390-6A96B611-F9B1-4363-9A5F-4A1EB62514DAQ27687191-D71AD103-68E2-4899-823F-1DF7D79F2ABFQ28078112-AD3D8D3D-5EE6-48A3-927C-4A81673F8FF5Q33354991-DBE7A888-6F35-4850-A7BC-23A2E8270A9BQ34251371-41885966-9D2C-4DFC-AA5D-A18660821F38Q35188575-11A4C7E2-307B-4C6E-8E3B-62217F5C5D3AQ35567748-9DA29D48-1E29-4BC0-8704-5DFE2FCE9EA1Q36109460-3AAB6CEA-4A25-4951-9843-C35BC92B8C43Q36193710-47526BC3-BB01-4946-806D-94613DCBE364Q36699251-4A9C93EF-B4C8-468A-B229-C4D987405F04Q36971789-4C1A47DE-E845-46E1-9634-A5ED9C829D8AQ37605562-2A613736-03B2-48ED-999C-6661BA5A8147Q37662511-C35D209C-AC49-4C53-BB4E-58B595CB3CCEQ37678199-04ADBD18-2D42-40E9-ACDA-BEAA1F736816Q37685135-1D7C250B-CBBC-4A6D-AD50-D62DD784BAF1Q38047362-1A3AC334-D66D-43FB-ADEA-B9702BC57964Q38094015-52098409-0865-4B47-AFB3-CE206C2350B1Q38094023-8C2EAF02-ABA3-4A24-AB11-235FF94DAED4Q38176953-61879CE7-F349-4F8D-B290-E99CE1228E45Q38197891-06970751-928B-483A-B364-CCCA853E795AQ38210793-489DD194-AF86-4E56-8F19-2FD7B952578CQ38235053-35F99902-F7BD-4462-8FFC-9533A52D82B9Q38247077-B194E976-CD6C-4947-9E3D-1ED87938EC3FQ38306933-D3663611-7F83-4F53-BCB1-D646FE7BBB9FQ38335718-42EBFC9A-44AD-4486-8B06-4A2A673AAD09Q38394726-C8E95CCD-AF40-4EEB-A3E6-915AD9738AD7Q38408897-EAD3D523-7BC5-4441-B9E3-BB6A8A5E3E6EQ38539281-1EAEE5AE-4FE5-4727-AE9A-FB0A7DD264C8Q38719498-388F6271-0472-4E0C-996F-A24612D0533EQ38883237-88E8ECC5-92A3-40D3-AB03-49AFC4CE3BCAQ40946497-E40A5BDC-74B0-47D9-BD44-6B62DE5D63BEQ42267006-583D35E2-BA69-4BDF-8D97-DFA8FCF3B882Q42978890-8A5AD84B-09D9-4C57-8490-FF82E96DEA97Q45352920-BFECCCB1-E8DF-4C4A-B394-D2292D732639Q45358091-B05F6D87-70B9-4D91-9C6F-0D876B230659Q45359644-6B4ACD03-44E8-4875-86B6-1C1D799E2169Q47112883-F2C32B76-A9AE-43B8-882E-60A088FC4FAF
P2860
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review article: prevention and ...... th inflammatory bowel disease.
@en
Review article: prevention and ...... th inflammatory bowel disease.
@nl
type
label
Review article: prevention and ...... th inflammatory bowel disease.
@en
Review article: prevention and ...... th inflammatory bowel disease.
@nl
prefLabel
Review article: prevention and ...... th inflammatory bowel disease.
@en
Review article: prevention and ...... th inflammatory bowel disease.
@nl
P50
P921
P1476
Review article: prevention and ...... ith inflammatory bowel disease
@en
P2093
P304
P356
10.1111/J.1365-2036.2010.04570.X
P407
P577
2011-03-01T00:00:00Z